COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT03814746
Brief Title: Study of Two Doses of Crizanlizumab Versus Placebo in Adolescent and Adult Sickle Cell Disease Patients (STAND)

First Submitted : January 21, 2019
First Submitted that Met QC Criteria : January 21, 2019
First Posted : January 24, 2019

Last Update Submitted that Met QC Criteria : July 31, 2020
Last Update Posted : August 3, 2020